Bicycle Therapeutics (BCYC) Shares Issued (2018 - 2026)

Bicycle Therapeutics (BCYC) has 8 years of Shares Issued data on file, last reported at $12000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 500.0% year-over-year to $12000.0; the trailing twelve-month figure through Mar 2026 stood at $47000.0 (down 99.17% YoY), and the FY2025 full-year result was $37000.0, down 99.51% from the prior year.
• Shares Issued for Q1 2026 stood at $12000.0, down from $33000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $19.4 million in Q3 2023 and bottomed at -$248.7 million in Q4 2023.
• The 5-year median for Shares Issued is $195000.0 (2022), against an average of -$12.0 million.
• The widest annual swing landed in 2023, when Shares Issued sank 5175.59%; it then jumped 93450.0% in 2024.
• A 5-year view of Shares Issued shows it stood at $4.9 million in 2022, then tumbled by 5175.59% to -$248.7 million in 2023, then jumped by 100.1% to $245000.0 in 2024, then plunged by 86.53% to $33000.0 in 2025, then tumbled by 63.64% to $12000.0 in 2026.
• The last three Shares Issued figures came in at $12000.0 (Q1 2026), $33000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.

Peer Comparison